Medirom Healthcare Technologies (MRM) Equity Average (2020 - 2024)
Medirom Healthcare Technologies has reported Equity Average over the past 4 years, most recently at $3.8 million for Q4 2024.
- Quarterly results put Equity Average at $3.8 million for Q4 2024, up 651.77% from a year ago — trailing twelve months through Dec 2024 was $3.8 million (up 651.77% YoY), and the annual figure for FY2024 was $3.8 million, up 651.77%.
- Equity Average for Q4 2024 was $3.8 million at Medirom Healthcare Technologies, up from $503174.6 in the prior quarter.
- Over the last five years, Equity Average for MRM hit a ceiling of $5.1 million in Q4 2020 and a floor of -$1.1 million in Q4 2022.
- Median Equity Average over the past 4 years was $2.1 million (2023), compared with a mean of $2.1 million.
- Biggest five-year swings in Equity Average: soared 144.66% in 2023 and later skyrocketed 651.77% in 2024.
- Medirom Healthcare Technologies' Equity Average stood at $5.1 million in 2020, then crashed by 122.04% to -$1.1 million in 2022, then soared by 144.66% to $503174.6 in 2023, then skyrocketed by 651.77% to $3.8 million in 2024.
- The last three reported values for Equity Average were $3.8 million (Q4 2024), $503174.6 (Q4 2023), and -$1.1 million (Q4 2022) per Business Quant data.